<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Neurosci</journal-id>
<journal-id journal-id-type="hwp">jneuro</journal-id>
<journal-id journal-id-type="pmc">jneurosci</journal-id>
<journal-id journal-id-type="publisher-id">J. Neurosci</journal-id>
<journal-title-group>
<journal-title>The Journal of Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0270-6474</issn>
<issn pub-type="epub">1529-2401</issn>
<publisher>
<publisher-name>Society for Neuroscience</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29118205</article-id>
<article-id pub-id-type="pmc">5678009</article-id>
<article-id pub-id-type="publisher-id">1840-17</article-id>
<article-id pub-id-type="doi">10.1523/JNEUROSCI.1840-17.2017</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Symposium and Mini-Symposium</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Epigenetic Etiology of Intellectual Disability</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-2280-7422</contrib-id>
<name>
<surname>Iwase</surname>
<given-names>Shigeki</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-1948-8715</contrib-id>
<name>
<surname>Bérubé</surname>
<given-names>Nathalie G.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Zhaolan</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-7448-9289</contrib-id>
<name>
<surname>Kasri</surname>
<given-names>Nael Nadif</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Battaglioli</surname>
<given-names>Elena</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scandaglia</surname>
<given-names>Marilyn</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-0653-3751</contrib-id>
<name>
<surname>Barco</surname>
<given-names>Angel</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<aff id="aff1"><sup>1</sup>University of Michigan Medical School, Medical Science II, Ann Arbor, Michigan 48109-5618, </aff>
<aff id="aff2"><sup>2</sup>Western University and Children's Health Research Institute, Victoria Research Laboratories, London, Ontario N6C 2V5, Canada, </aff>
<aff id="aff3"><sup>3</sup>Department of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104-6145, </aff>
<aff id="aff4"><sup>4</sup>Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Centre, 6500 HB, Nijmegen, The Netherlands, </aff>
<aff id="aff5"><sup>5</sup>University of Milan, Department Medical Biotechnology and Translational Medicine, 20090 Segrate (MI), Italy, and </aff>
<aff id="aff6"><sup>6</sup>Instituto de Neurociencias, Molecular Neurobiology Unit, s/n 03550, San Juan de Alicante, Alicante, Spain</aff>
</contrib-group>
<author-notes>
<corresp>Correspondence should be addressed to Dr. Angel Barco,
<addr-line>Instituto de Neurociencias, Molecular Neurobiology Unit, Av Santiago Ramon y Cajal, s/n 03550, San Juan de Alicante, Alicante, Spain.</addr-line><email>abarco@umh.es</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>8</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>8</day>
<month>5</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 6 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>37</volume>
<issue>45</issue>
<fpage>10773</fpage>
<lpage>10782</lpage>
<history>
<date date-type="received">
<day>17</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>26</day>
<month>9</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>9</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 the authors 0270-6474/17/3710773-10$15.00/0</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="zns04517010773.pdf"></self-uri>
<abstract>
<p>Intellectual disability (ID) is a prevailing neurodevelopmental condition associated with impaired cognitive and adaptive behaviors. Many chromatin-modifying enzymes and other epigenetic regulators have been genetically associated with ID disorders (IDDs). Here we review how alterations in the function of histone modifiers, chromatin remodelers, and methyl-DNA binding proteins contribute to neurodevelopmental defects and altered brain plasticity. We also discuss how progress in human genetics has led to the generation of mouse models that unveil the molecular etiology of ID, and outline the direction in which this field is moving to identify therapeutic strategies for IDDs. Importantly, because the chromatin regulators linked to IDDs often target common downstream genes and cellular processes, the impact of research in individual syndromes goes well beyond each syndrome and can also contribute to the understanding and therapy of other IDDs. Furthermore, the investigation of these disorders helps us to understand the role of chromatin regulators in brain development, plasticity, and gene expression, thereby answering fundamental questions in neurobiology.</p>
</abstract>
<kwd-group>
<kwd>α-thalassemia mental retardation syndrome</kwd>
<kwd>Claes-Jensen syndrome</kwd>
<kwd>DNA methylation</kwd>
<kwd>histone posttranslational modification</kwd>
<kwd>Kleefstra syndrome</kwd>
<kwd>neuroepigenetics</kwd>
<kwd>Rett syndrome</kwd>
<kwd>Rubinstein-Taybi syndrome</kwd>
<kwd>X-linked intellectual disability</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>